|
AVXL
|
Anavex Life Sciences Corp.
|
0.07%
|
US
|
NASDAQ
|
|
ANIP
|
ANI Pharmaceuticals, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
ADMA
|
ADMA Biologics Inc
|
0.07%
|
US
|
NASDAQ
|
|
ALT
|
Altimmune, Inc.
|
0.07%
|
US
|
NASDAQ
|
|
RPTX
|
Repare Therapeutics Inc.
|
0.06%
|
US
|
NASDAQ
|
|
MCRB
|
Seres Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
ITOS
|
iTeos Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
ICPT
|
Intercept Pharmaceuticals, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
0.06%
|
US
|
NASDAQ
|
|
CSTL
|
Castle Biosciences, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
ANAB
|
AnaptysBio, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
AMRN
|
Amarin Corporation plc
|
0.06%
|
US
|
NASDAQ
|
|
ALLK
|
Allakos Inc.
|
0.06%
|
US
|
NASDAQ
|
|
ALEC
|
Alector, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
HCM
|
Hutchison China MediTech Limited
|
0.06%
|
US
|
NASDAQ
|
|
DYN
|
Dyne Therapeutics, Inc.
|
0.06%
|
US
|
NASDAQ
|
|
ME
|
23andMe Holding Co.
|
0.06%
|
US
|
NASDAQ
|
|
MXCT
|
Maxcyte Inc
|
0.05%
|
UK
|
LSE
|
|
STRO
|
Sutro Biopharma, Inc.
|
0.05%
|
US
|
NASDAQ
|